Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BARIVA: Rivaroxaban for VTE prophylaxis after bariatric surgery
NCT03522259Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Jul 2018
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rivaroxaban in venous thromboembolism (VTE), sponsored by Insel Gruppe. Started Jul 2018; status: completed.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03522259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03522259.